DOI : 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue S 1 · Volume 115 · 2007 DOI: 10.1055/s-002-5619


51. Annual Meeting of the German Society of Endocrinology (DGE)
Salzburg, 7-10 March 2007

Congress-President of the DGE: Prof. Dr. med. Michael Buchfelder, Erlangen-Nürnberg; Congress-President of the ÖGES: Prof. Dr. med. Anton Luger, Wien
Abstracts (HTML) List of Authors
P01_052
Nüsken, K. D.; Petrasch, M.; Rauh, M.; Stöhr, W.; Nüsken, E.; Schneider, H.; Dötsch, J.: Reduced plasma visfatin in end-stage renal disease is associated with reduced body fat mass and elevated serum insulin
P01_053
Höfle, G.; Saely, C. H.; Risch, L.; Rein, P.; Koch, L.; Schmid, F.; Aczél, S.; Marte, T.; Langer, P.; Drexel, H.: Leptin, leptin soluble receptor and coronary atherosclerosis
P01_054
Schinner, S.; Ülgen, F.; Schott, M.; Scherbaum, W. A.: Adipocytes induce insulin secretion and glucokinase gene transcription in pancreatic beta-cells through the Wnt-signalling pathway
P01_055
Garten, A.; Körner, A.; Tauscher, R.; Berthold, A.; Kratzsch, J.; Kiess, W.: Visfatin – an activator of the insulin signalling pathway?
P01_056
Höfle, G.; Saely, C. H.; Risch, L.; Koch, L.; Schmid, F.; Aczél, S.; Berchtold, S.; Marte, T.; Drexel, H.: Impact of resistin on the incidence of vascular events in patients undergoing coronary angiography
P01_057
Körner, A.; Kratzsch, J.; Garten, A.; Blüher, M.; Kiess, W.: The tale of visfatin – or: About knowing what to measure ..
P01_058
Möhlig, M.; Ghadamgahi, E.; Weickert, M. O.; Arafat, A. M.; Spranger, J.; Pfeiffer, A. F. H.; Schöfl, C.: FABP-A correlates with body fat mass in PCOS women
P01_059
Vleugels, K.; Schinner, S.; Buro, U.; Sperber, S.; Bornstein, S. R.; Ehrhart-Bornstein, M.; Krug, A. W.: Adipocyte-induced ERK1/2-mediated StAR activation enhances aldosterone secretion and sensitizes human adrenocortical cells to AngII
P01_060
Göncz, E.; Grötzinger, C.; Mergler, S.; El-Zayat, B. F.; Theodoropoulou, M.; Stalla, G. K.; Wiedenmann, B.; Strowski, M. Z.; Plöckinger, U.: Orexin-A inhibits glucagon secretion and gene expression by Foxo1 dependent pathway
P01_061
Wellhöner, P.; Klages, A.; Sayk, F.; Dodt, C.: Effect of intranasally administered MSH/ACTH 4–10 on skeletal muscle and adipose tissue metabolism in young men
P01_062
Bollheimer, L. C.; Wobser, H.; Wrede, C. E.; Schäffler, A.; Schölmerich, J.; Büchler, C.; Buettner, R.: Glucagon under high fat diet induced obesity
P01_063
Körner, A.; Kovacs, P.; Berndt, J.; Stumvoll, M.; Kiess, W.: TCF7L2-gene polymorphisms confer an increased risk for early impairment of glucose metabolism and increased height in obese children
P01_064
Fischer-Posovszky, P.; Kukulus, V.; Killian, A.; Debatin, K. M.; Wabitsch, M.: Effects of resveratrol on human adipocyte biology
P01_065
Wiegand, S.; Richardt, A.; Remer, T.; Wudy, S. A.; Tomlinson, J. W.; Grüters, A.; Stewart, P. M.; Strasburger, C. J.; Quinkler, M.: 11beta-hydroxysteroid dehydrogenase type 1 in obese children